Clinical Trial Update: Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM [Phase 3]

View source ↗

Summary

Phase 3 trial comparing GSK's MMRV vaccine to Priorix; the study is completed and results were posted on 2017-09-25.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Measles
• Mumps
• Rubella
• Varicella

Drugs mentioned

• GSK MMRV vaccine (Measles, mumps, rubella, varicella vaccine (MMRV))
• Priorix (Measles-Mumps-Rubella Vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Varicella, Rubella | Phase 3 | Status: COMPLETED | Results posted: 2017-09-25